Heterozygous mutations in either ENDOGLIN (ENG) or ACVRL1/ALK1 genes trigger the pathogenesis of HHT in over 90% of HHT patients [6,7]. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.